Stay updated with breaking news from Beckley Psytech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- PSYCH, the premium business-to-business media and content platform for the psychedelic science and healthcare industry, today announced the...
Phase Ib trial is evaluating the potential benefit of low-dose psilocybin as a treatment for SUNHA - News - PharmaTimes
Investegate announcements from Clarify Pharma PLC, Clarify Pharma Makes First Capital Investment
TRADING UPDATES: Chrysalis backs InfoSum; Argo Blockchain goes green | Financial News
An Oxford based company which uses psychedelic medicines to treat neurological disorders has completed an oversubscribed £58m funding round.